David Schenkein, M.D.
DirectoratPrime Medicine· In proxies 2023–2025
David Schenkein, M.D. sits on 5 public boards.
Experience
- Prime MedicinePublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -70%
- Aera Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Denali Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Leyden Laboratories B.V.Public company
- Director? – PresentNo stock prices for these years
- Regeneron Pharmaceuticals, IncPublic company
- Director? – PresentNo stock prices for these years
- Treeline Biosciences, IncPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?